Cargando…

Feasibility and mechanism analysis of Reduning in the prevention of sepsis-induced pulmonary fibrosis

Introduction: The increasing mortality in patients with sepsis-induced pulmonary fibrosis owes to a lack of effective treatment options. This study aims to explore the possibility and possible targets of Reduning in the prevention of sepsis-related pulmonary fibrosis. Methods: The active components...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ziyi, Liu, Yuxin, Chen, Feng, Liao, Haiyan, Wang, Xuesong, Guo, Zhe, Wang, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810142/
https://www.ncbi.nlm.nih.gov/pubmed/36605402
http://dx.doi.org/10.3389/fphar.2022.1079511
_version_ 1784863248690970624
author Wang, Ziyi
Liu, Yuxin
Chen, Feng
Liao, Haiyan
Wang, Xuesong
Guo, Zhe
Wang, Zhong
author_facet Wang, Ziyi
Liu, Yuxin
Chen, Feng
Liao, Haiyan
Wang, Xuesong
Guo, Zhe
Wang, Zhong
author_sort Wang, Ziyi
collection PubMed
description Introduction: The increasing mortality in patients with sepsis-induced pulmonary fibrosis owes to a lack of effective treatment options. This study aims to explore the possibility and possible targets of Reduning in the prevention of sepsis-related pulmonary fibrosis. Methods: The active components and targets of Reduning were searched and screened from the database and analysis platform of traditional Chinese medicine (TCM) system pharmacology. GeneCards, human genome database, DisGeNET database, and the OMIM database were checked to determine the targets associated with sepsis-induced pulmonary fibrosis. DAVID Bioinformatics Resources 6.8 was used for GO and KEGG enrichment analysis to predict its possible signaling pathways and explore its molecular mechanism. The protein–protein interaction (PPI) network was used to identify key active components and core targets. Molecular docking technology was applied to screen the complexes with stable binding of key active components and core targets. Molecular dynamics simulations were used to verify the binding stability and molecular dynamics characteristics of the complexes. The protective effect of RDN on sepsis-induced pulmonary fibrosis was verified by in vitro and in vivo experiments. Results: There were 319 shared targets between sepsis-induced pulmonary fibrosis and RDN. GO enrichment analysis showed that they mainly regulated and participated in the positive regulation of kinase activity, mitogen-activated protein kinase (MAPK) cascade, and protein phosphorylation. KEGG enrichment analysis showed that they were mainly enriched in the mitogen-activated protein kinase cascade signaling pathway, the calcium signaling pathway, the apoptosis pathway, and other signaling pathways. The results of molecular docking and molecular dynamics simulations showed that the active components, stigmasterol, beta-sitosterol, and quercetin, had good binding activities with ERBB2, and they exhibited good stability. Molecular validation experiments confirmed RDN could alleviate lung fibrosis induced by cecum ligation and puncture (CLP), in parallel with the inhibition of the ERBB2-p38 MAPK pathway in mouse alveolar macrophages (AMs). Discussion: Reduning may prevent sepsis-induced pulmonary fibrosis by regulating the ERBB2-p38 MAPK signaling pathway, which provides a possibility for the prevention of sepsis-induced pulmonary fibrosis with traditional Chinese medicine.
format Online
Article
Text
id pubmed-9810142
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98101422023-01-04 Feasibility and mechanism analysis of Reduning in the prevention of sepsis-induced pulmonary fibrosis Wang, Ziyi Liu, Yuxin Chen, Feng Liao, Haiyan Wang, Xuesong Guo, Zhe Wang, Zhong Front Pharmacol Pharmacology Introduction: The increasing mortality in patients with sepsis-induced pulmonary fibrosis owes to a lack of effective treatment options. This study aims to explore the possibility and possible targets of Reduning in the prevention of sepsis-related pulmonary fibrosis. Methods: The active components and targets of Reduning were searched and screened from the database and analysis platform of traditional Chinese medicine (TCM) system pharmacology. GeneCards, human genome database, DisGeNET database, and the OMIM database were checked to determine the targets associated with sepsis-induced pulmonary fibrosis. DAVID Bioinformatics Resources 6.8 was used for GO and KEGG enrichment analysis to predict its possible signaling pathways and explore its molecular mechanism. The protein–protein interaction (PPI) network was used to identify key active components and core targets. Molecular docking technology was applied to screen the complexes with stable binding of key active components and core targets. Molecular dynamics simulations were used to verify the binding stability and molecular dynamics characteristics of the complexes. The protective effect of RDN on sepsis-induced pulmonary fibrosis was verified by in vitro and in vivo experiments. Results: There were 319 shared targets between sepsis-induced pulmonary fibrosis and RDN. GO enrichment analysis showed that they mainly regulated and participated in the positive regulation of kinase activity, mitogen-activated protein kinase (MAPK) cascade, and protein phosphorylation. KEGG enrichment analysis showed that they were mainly enriched in the mitogen-activated protein kinase cascade signaling pathway, the calcium signaling pathway, the apoptosis pathway, and other signaling pathways. The results of molecular docking and molecular dynamics simulations showed that the active components, stigmasterol, beta-sitosterol, and quercetin, had good binding activities with ERBB2, and they exhibited good stability. Molecular validation experiments confirmed RDN could alleviate lung fibrosis induced by cecum ligation and puncture (CLP), in parallel with the inhibition of the ERBB2-p38 MAPK pathway in mouse alveolar macrophages (AMs). Discussion: Reduning may prevent sepsis-induced pulmonary fibrosis by regulating the ERBB2-p38 MAPK signaling pathway, which provides a possibility for the prevention of sepsis-induced pulmonary fibrosis with traditional Chinese medicine. Frontiers Media S.A. 2022-12-20 /pmc/articles/PMC9810142/ /pubmed/36605402 http://dx.doi.org/10.3389/fphar.2022.1079511 Text en Copyright © 2022 Wang, Liu, Chen, Liao, Wang, Guo and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Ziyi
Liu, Yuxin
Chen, Feng
Liao, Haiyan
Wang, Xuesong
Guo, Zhe
Wang, Zhong
Feasibility and mechanism analysis of Reduning in the prevention of sepsis-induced pulmonary fibrosis
title Feasibility and mechanism analysis of Reduning in the prevention of sepsis-induced pulmonary fibrosis
title_full Feasibility and mechanism analysis of Reduning in the prevention of sepsis-induced pulmonary fibrosis
title_fullStr Feasibility and mechanism analysis of Reduning in the prevention of sepsis-induced pulmonary fibrosis
title_full_unstemmed Feasibility and mechanism analysis of Reduning in the prevention of sepsis-induced pulmonary fibrosis
title_short Feasibility and mechanism analysis of Reduning in the prevention of sepsis-induced pulmonary fibrosis
title_sort feasibility and mechanism analysis of reduning in the prevention of sepsis-induced pulmonary fibrosis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810142/
https://www.ncbi.nlm.nih.gov/pubmed/36605402
http://dx.doi.org/10.3389/fphar.2022.1079511
work_keys_str_mv AT wangziyi feasibilityandmechanismanalysisofreduninginthepreventionofsepsisinducedpulmonaryfibrosis
AT liuyuxin feasibilityandmechanismanalysisofreduninginthepreventionofsepsisinducedpulmonaryfibrosis
AT chenfeng feasibilityandmechanismanalysisofreduninginthepreventionofsepsisinducedpulmonaryfibrosis
AT liaohaiyan feasibilityandmechanismanalysisofreduninginthepreventionofsepsisinducedpulmonaryfibrosis
AT wangxuesong feasibilityandmechanismanalysisofreduninginthepreventionofsepsisinducedpulmonaryfibrosis
AT guozhe feasibilityandmechanismanalysisofreduninginthepreventionofsepsisinducedpulmonaryfibrosis
AT wangzhong feasibilityandmechanismanalysisofreduninginthepreventionofsepsisinducedpulmonaryfibrosis